Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 107M | 956M | 1.9B | 221M |
Cost of revenue | 90M | 739M | 514M | 115M |
Gross profit | 17M | 217M | 1.3B | 106M |
Operating expense | ||||
Research & development | 856M | 1.1B | 1.1B | 1.2B |
Selling general and admin | 212M | 351M | 281M | 268M |
Other operating expenses | -1M | -10M | -7M | -20M |
Operating income | -1.1B | -1.2B | -70M | -1.4B |
Non operating interest income | ||||
Income | 90M | 91M | 103M | 111M |
Expense | 1M | 6M | 6M | 6M |
Other income expense | -3M | -23M | -6M | -21M |
Pretax income | -964M | -1.2B | 21M | -1.3B |
Tax provision | 7M | -64M | 8M | 0 |
Net income | -971M | -1.1B | 13M | -1.3B |
Basic EPS | -2.5 | -2.9 | 0.0 | -3.3 |
Diluted EPS | -2.5 | -2.9 | 0.0 | -3.3 |
Basic average shares | 386M | 385M | 385M | 384M |
Diluted average shares | 386M | 385M | 399M | 384M |
EBITDA | -917M | -1.1B | 88M | -1.2B |
Net income from continuing op. | -971M | -1.1B | 13M | -1.3B |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |